Stem Cell Therapy for Myocardial Repair

心肌修复的干细胞疗法

基本信息

  • 批准号:
    9281559
  • 负责人:
  • 金额:
    $ 73.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2020-04-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT Myocardial infarction often induces a period of left ventricular (LV) remodeling. When LV remodeling occurs, an initial period of hemodynamic stability is followed by the development of LV dysfunction that may result in congestive heart failure (CHF). The molecular and cellular basis for the progressive heart failure is the result of the inability of damaged and apoptotic myocytes to be replaced. Although there are a significant number of reports in recent literature on cellular therapy for myocardial repair using different type of stem cells, the low engraftment rate, as well as the low cardiomyocytes regeneration are the major problems in cardiac cell therapy. The proposed studies will utilize pre differentiated myocytes and vascular cells derived from human induced pluripotent stem cells (hiPSCs) in a porcine model of postinfarction LV remodeling with immune suppression that we have previously demonstrated to be very relevant to human clinical cardiac regenerative therapies. Here we will pursue the following specific aims. Specific Aim 1: To use submicron 3D printing to fabricate ECM-based hydrogels based on the distribution of ECM in the native myocardium to generate a myocardial tissue equivalent with enhanced function of iPSC-derived tri-lineage cardiac cell types. Specific Aim 2: Using the recently established T1-nom P-31 magnetization saturation transfer (MST) and 2D chemical shifting imaging (2D-CSI) methods to examine whether the myocardial ATP flux rate via both CK and ATPase are most severely altered in the periscar border zone subendocardial layers (ENDO) of infarcted hearts. The severity of the decrease in ATP production capacity via CK and ATPase in ENDO of the infarcted heart is linearly related to the severity of the LV dysfunction. Specific Aim 3: To examine whether the functional beneficial effects of transplantation of the novel ECM tissue equivalent using human iPSC-CM, -endothelial cells (EC) and –smooth muscle cells (SMC) are accompanied by enhanced retention and integration of transplanted cells to the myocardium and associated reduction of LV wall stress, which in turn results in improvement of myocardial ATP production reserve via both CK and ATPase in the ENDO of infarcted hearts. The results of these studies may lead to better diagnostic and therapeutic modalities for acute myocardial infarction.
摘要 心肌梗死常引起一段时间的左心室(LV)重构。当LV重构发生时, 血流动力学稳定的初始阶段之后是LV功能障碍的发展,可能导致 充血性心力衰竭(CHF)。进行性心力衰竭的分子和细胞基础是 受损和凋亡的肌细胞不能被替换。虽然有相当数量的 在最近关于使用不同类型的干细胞进行心肌修复的细胞疗法的文献中, 移植率以及心肌细胞再生率低是心肌细胞治疗中的主要问题。 拟议的研究将利用来自人诱导的预分化的肌细胞和血管细胞, 多能干细胞(hiPSC)在具有免疫抑制的梗死后LV重构的猪模型中的作用, 我们先前已经证明其与人类临床心脏再生治疗非常相关。这里我们 将致力于实现以下具体目标。具体目标1:使用亚微米3D打印来制造基于ECM的 基于ECM在天然心肌中的分布的水凝胶,以产生心肌组织等效物 具有增强的iPSC衍生的三系心脏细胞类型的功能。目标2:最近使用 建立T1-nom P-31磁化饱和转移(MST)和2D化学位移成像(2D-CSI) 方法检查是否心肌ATP通量率通过CK和ATP酶是最严重的改变 在梗死心脏的边缘区内膜下层(ENDO)中。减少的严重程度 心肌梗死后,通过CK和ATP酶的ENDO产生ATP的能力与心肌梗死的严重程度呈线性相关。 左心室功能障碍具体目标3:检查移植的功能性有益作用是否 使用人iPSC-CM的新型ECM组织等同物,-内皮细胞(EC)和-平滑肌细胞(SMC) 伴随着移植细胞向心肌的保留和整合的增强, 减少左室壁应力,从而通过两者改善心肌ATP产生储备 心肌梗死后心内膜组织中CK和ATP酶的变化。这些研究的结果可能会导致更好的诊断和 急性心肌梗死的治疗方式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brenda M Ogle其他文献

Brenda M Ogle的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brenda M Ogle', 18)}}的其他基金

Epicardial regulation of cardiomyocyte function via modulation of extracellular signals: toward a model of human muscle pump function
通过细胞外信号调节心肌细胞功能的心外膜调节:人类肌肉泵功能模型
  • 批准号:
    10755812
  • 财政年份:
    2023
  • 资助金额:
    $ 73.3万
  • 项目类别:
Epicardial regulation of cardiomyocyte function via modulation of extracellular signals: toward a model of human muscle pump function
通过细胞外信号调节心肌细胞功能的心外膜调节:人类肌肉泵功能模型
  • 批准号:
    10812552
  • 财政年份:
    2022
  • 资助金额:
    $ 73.3万
  • 项目类别:
Epicardial regulation of cardiomyocyte function via modulation of extracellular signals: toward a model of human muscle pump function
通过细胞外信号调节心肌细胞功能的心外膜调节:人类肌肉泵功能模型
  • 批准号:
    10640175
  • 财政年份:
    2022
  • 资助金额:
    $ 73.3万
  • 项目类别:
Intrinsic fluorescence to guide characterization and purification of stem cells
内在荧光指导干细胞的表征和纯化
  • 批准号:
    7815748
  • 财政年份:
    2010
  • 资助金额:
    $ 73.3万
  • 项目类别:
Directed Cell Fusion for the Treatment of Myocardial Infarction
定向细胞融合治疗心肌梗塞
  • 批准号:
    7799324
  • 财政年份:
    2009
  • 资助金额:
    $ 73.3万
  • 项目类别:
Directed Cell Fusion for the Treatment of Myocardial Infarction
定向细胞融合治疗心肌梗塞
  • 批准号:
    7659257
  • 财政年份:
    2009
  • 资助金额:
    $ 73.3万
  • 项目类别:
Directed Cell Fusion for the Treatment of Myocardial Infarction
定向细胞融合治疗心肌梗塞
  • 批准号:
    7841105
  • 财政年份:
    2009
  • 资助金额:
    $ 73.3万
  • 项目类别:
T cell compartment dynamics following thymectomy
胸腺切除术后 T 细胞区室动力学
  • 批准号:
    6819837
  • 财政年份:
    2004
  • 资助金额:
    $ 73.3万
  • 项目类别:
T cell compartment dynamics following thymectomy
胸腺切除术后 T 细胞区室动力学
  • 批准号:
    7278504
  • 财政年份:
    2004
  • 资助金额:
    $ 73.3万
  • 项目类别:
T cell compartment dynamics following thymectomy
胸腺切除术后 T 细胞区室动力学
  • 批准号:
    7485106
  • 财政年份:
    2004
  • 资助金额:
    $ 73.3万
  • 项目类别:

相似海外基金

Exploring the effect of ATP hydrolysis on condensin ability to compact chromosomes
探索 ATP 水解对浓缩蛋白压缩染色体能力的影响
  • 批准号:
    364619
  • 财政年份:
    2017
  • 资助金额:
    $ 73.3万
  • 项目类别:
The Mechanism and Regulation of ATP Hydrolysis in a Viral Genome Packaging Motor
病毒基因组包装马达中 ATP 水解的机制和调控
  • 批准号:
    9327813
  • 财政年份:
    2017
  • 资助金额:
    $ 73.3万
  • 项目类别:
Analysis of coupling between substrate binding and ATP hydrolysis in canonical homo- and heterodimeric amino acid ABC import systems
经典同二聚体和异二聚体氨基酸 ABC 输入系统中底物结合与 ATP 水解之间的耦合分析
  • 批准号:
    315832426
  • 财政年份:
    2016
  • 资助金额:
    $ 73.3万
  • 项目类别:
    Research Grants
Mechanisms of actin polymerization, ATP hydrolysis, and filament severing revealed by F-form crystal structures
F 型晶体结构揭示肌动蛋白聚合、ATP 水解和丝断裂的机制
  • 批准号:
    16K14708
  • 财政年份:
    2016
  • 资助金额:
    $ 73.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Identification of key residues for control of the coupling between ATP hydrolysis and substrate transport of an ABC transporter
鉴定控制 ABC 转运蛋白 ATP 水解和底物转运之间耦合的关键残基
  • 批准号:
    26840048
  • 财政年份:
    2014
  • 资助金额:
    $ 73.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Multisubunit viral ATPases that couple ATP-hydrolysis to genome translocation
将 ATP 水解与基因组易位耦合的多亚基病毒 ATP 酶
  • 批准号:
    8238803
  • 财政年份:
    2012
  • 资助金额:
    $ 73.3万
  • 项目类别:
Multisubunit viral ATPases that couple ATP-hydrolysis to genome translocation
将 ATP 水解与基因组易位耦合的多亚基病毒 ATP 酶
  • 批准号:
    9754155
  • 财政年份:
    2012
  • 资助金额:
    $ 73.3万
  • 项目类别:
Multisubunit viral ATPases that couple ATP-hydrolysis to genome translocation
将 ATP 水解与基因组易位耦合的多亚基病毒 ATP 酶
  • 批准号:
    8518398
  • 财政年份:
    2012
  • 资助金额:
    $ 73.3万
  • 项目类别:
Multisubunit viral ATPases that couple ATP-hydrolysis to genome translocation
将 ATP 水解与基因组易位耦合的多亚基病毒 ATP 酶
  • 批准号:
    8711498
  • 财政年份:
    2012
  • 资助金额:
    $ 73.3万
  • 项目类别:
Multisubunit viral ATPases that couple ATP-hydrolysis to genome translocation
将 ATP 水解与基因组易位耦合的多亚基病毒 ATP 酶
  • 批准号:
    8927018
  • 财政年份:
    2012
  • 资助金额:
    $ 73.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了